diabetestalk.net

Journal Of Diabetes Research And Therapy Impact Factor

Jmir Diabetes

Jmir Diabetes

"Excellent (5/5) - The editor and the reviewers assessed my manuscript in a very efficient and yet thorough manner. The communication was all very clear throughout the process." Anonymous Review on SciRev.sc View Theme View All Themes Background: Personalized blood glucose (BG) prediction for diabetes patients is an important goal that is pursued by many researchers worldwide. Despite many proposals, only a few projects are dedicated to the development of complete recommender system infrastructures that incorporate BG prediction algorithms for diabetes patients. The development and implementation of such a system aided by mobile technology is of particular interest to patients with gestational diabetes mellitus (GDM), especially considering the significant importance of quickly achieving adequate BG control for these patients in a short period (ie, during pregnancy) and a typically higher acceptance rate for mobile health (mHealth) solutions for short- to midterm usage. Objective: This study was conducted with the objective of developing infrastructure comprising data processing algorithms, BG prediction models, and an appropriate mobile app for patients’ electronic record management to guide BG prediction-based personalized recommendations for patients with GDM. Methods: A mobile app for electronic diary management was developed along with data exchange and continuous BG signal processing software. Both components were coupled to obtain the necessary data for use in the personalized BG prediction system. Necessary data on meals, BG measurements, and other events were collected via the implemented mobile app and continuous glucose monitoring (CGM) system processing software. These data were used to tune and evaluate the BG prediction model, which included an algorithm Continue reading >>

Indexing And Impact Factor

Indexing And Impact Factor

A dedicated BMRAT indexing team is working to include all of our journals in reputed indexing services or journal evaluation services. As a result, within a short span of time our journals have been included in some major indexing databases or journal evaluation services and the number is increasing every month. Biomedical Research and Therapyis indexed and abstracted by: No new journal, even published by the top most publishers, can have ISI impact factor in first two years of operation. As per the rules of ISI, any new journal may get its first impact factor after two years of operation (See more information in this regard at the official web page of ISI or in wikipedia ). The impact factor of a journal reflects the frequency with which the journal's articles are cited in the scientific literature. It is derived by dividing the number of citations in year 3 to any items published in the journal in years 1 and 2 by the number of substantive articles published in that journal in years 1 and 2 The 2008 impact factor of a journal would be calculated as follows: A = the number of times articles published in 2006 and 2007 were cited by indexed journals during 2008 B = the total number of "citable items" published by that journal in 2006 and 2007. ("Citable items" are usually articles, reviews, proceedings, or notes; not editorials or Letters-to-the-Editor.) (Note that 2008 impact factors are actually published in 2009; they cannot be calculated until all of the 2008 publications have been processed by the indexing agency.) New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1 are Continue reading >>

What Is The Impact Factor Of The Journal Of Diabetes Research For 2013?

What Is The Impact Factor Of The Journal Of Diabetes Research For 2013?

Controversies in Treating Diabetes: Clinical and Research Aspects [Show abstract] [Hide abstract] ABSTRACT: As an endocrinologist, I have educated countless patients with diabetes mellitus about the importance of maintaining good glycemic control. Indeed, currently there is no dispute that inadequate glycemic control contributes to some of the long-term complications of diabetes. However, not too long ago, it was controversial whether lowering blood glucose levels in patients with diabetes would have any beneficial effects. Medicine is filled with such controversies, which usually result from insufficient or conflicting data, and the field of diabetes is no exception. Currently, the scientific community is divided on whether rosiglitazone, a peroxisome proliferator-activated receptor agonist indicated for the treatment of type 2 diabetes, increases the risk of myocardial ischemic events. This finding is based on a meta-analysis of short-term clinical trials and has not been confirmed in longer-term clinical trials. In 2008, a large clinical trial in patients with type 2 diabetes at high cardiovascular risk reported an unexpected finding of increased mortality among patients randomized to undergo near-normal glycemic control compared with those randomized to undergo conventional glycemic control. In contrast, intensive glycemic control did not increase mortality in 2 other recently completed clinical trials. Content validity of the PedsQL 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 845 [Show abstract] [Hide abstract] ABSTRACT: Objectives: The content validity of the 28-item PedsQL 3.0 Diabetes Module has not been established in research on pediatric and adult patients with newly diagnosed Type 1 diabetes across a broad age range. T Continue reading >>

Journal Of Diabetes - Wiley Online Library

Journal Of Diabetes - Wiley Online Library

Edited By: Zachary T. Bloomgarden and Guang Ning ISI Journal Citation Reports @ Ranking: 2017:62/143 (Endocrinology & Metabolism) Journal of Diabetes now offers CME credits to peer reviewers of original contributions to medical literature. For more information, please refer to the CME for Reviewers page. Call for Young Scholars as Peer Reviewers To help early career researchers better understand the peer review process and standards, and to see your own research through the lens of a reviewer, as well as to improve the peer review speed and quality for JDB, we are now recruiting young reviewer volunteers to participate as our reviewers. 3. Have reviewed papers for other journals (preferably) Brain atrophy in middleaged subjects with Type 2 diabetes mellitus, with and without microvascular complications Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3 (NLRP3) inflammasome in diabetic rats High dietary intake of branchedchain amino acids is associated with an increased risk of insulin resistance in adults Performance of nontraditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes Continue reading >>

Endocrinology & Diabetes Research

Endocrinology & Diabetes Research

Endocrinology & Diabetes Research (ECDR) is a peer-reviewed scholarly journal that publishes the most complete and reliable source of information in advancing knowledge for endocrinology and diabetes. ECDR aims to promote rigorous research on the discoveries and current research developments in the mode of original articles, review articles, case reports, short communications, etc. in all major themes pertaining to endocrinology, metabolism and diabetes. Endocrinology & Diabetes Research is a subscription based journal that provides a range of options to purchase our articles and also permits unlimited Internet Access to complete Journal content. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields and that the information they contain is accurate and reliable. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process. Submit manuscript at www.editorialmanager.com/scitechnol/default.aspx or send as an e-mail attachment to the Editorial Office at [email protected] or [email protected] Impact factor Journal Impact Factor is the ratio of the number of citations achieved in the year 2016 based on Google Search and Google Scholar Citations to the total number of articles published in the last two years i.e. in 2014 and 2015. Impact factor measures the quality of the Journal. If ‘X’ is the total number of articles published in 2014 and 2015, and ‘Y’ is the number of times these articles were cited in indexed journals during 2 Continue reading >>

Journal Of Cardiology And Therapy

Journal Of Cardiology And Therapy

You can also submit your article to us by email: [email protected] Editorial Office of Journal of Cardiology and Therapy Journal print copy or article reprints are available for order, please contact: [email protected] Online Access This is a fully open access journal, the full texts (in HTML and PDF) of all articles can be viewed online for free immediately after publishing. Permission For permission, please contact the editorial office directly: ISSN-Online: 2312-122X; Frequency: Biannually, Instant published; The first Issue: June, 2013; Full Open Access; Publishing fee SCOPE: The journal publishes research papers in areas of research include, but are not limited to, the following: arrhythmias, heart failure, vascular disease, stroke, hypertension, prevention and epidemiology, dyslipidemia and metabolic related to cardiology: arrhythmias, heart failure, vascular disease, stroke, hypertension, prevention and epidemiology, dyslipidemia and metabolic disorders, cardiac imaging, paediatrics, nursing, and health promotion. MISSION: The mission of the journal is the rapid exchange of scientific information between clinicians and scientists worldwide, seeks to publish high-quality practical and clinical research around new and existing therapies in all areas of cardiology. The mission of the journal is the rapid exchange of scientific information between clinicians and scientists worldwide. Juei-Tang Cheng, Chair-Professor, Ph.D., F.C.P, Institute of Medical Research, Chang Jung Christian University, Tainan City, Taiwan; Society Memberships: American Diabetes Association (2000); New York Academy of Sciences (1996); International Brain Research Organization (1994); Asian Society of Neurochemistry (1994); Japan Society of Pharmacology (1978). More Figure 1. Panels A to C. Segme Continue reading >>

Diabetes, Metabolic Syndrome And Obesity: Targets And Therapy

Diabetes, Metabolic Syndrome And Obesity: Targets And Therapy

An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication. This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). Indexed online: Continue reading >>

Journal Of Diabetology - Free Full Text Articles From Journal Of Diabetology

Journal Of Diabetology - Free Full Text Articles From Journal Of Diabetology

Cardiovascular safety studies for diabetic medications: Do the benefits outweigh the costs? Since 2005, the Food and Drug Administration (FDA) has approved dozens of new options (including combination products) in the treatment of diabetes, providing clinicians with a plethora of treatment... Technology in the management of diabetes mellitus The explosive increase in the prevalence of diabetes mellitus in resource-strapped regions of the world demands innovative solutions in healthcare. Advances in information technology, diagnostics an... Low-density lipoprotein cholesterol (LDL-C) has been proven time and again to be independently associated with the risk of cardiovascular diseases (CVD). However, triglycerides (TG) are now also eme... Depressive symptoms among participants with type 2 diabetes in Southeast Asia: A systematic review Objective: Diabetes and depression are two major non-communicable diseases that have increased in epidemic proportion globally. Depression is common in participants with diabetes causing incr... [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] Association of cardiovascular complications with circulating levels of tribbles 3 human homolog and matrix metalloproteinases in Indian type 2 diabetic patients, with or without hypertension Aim and Objective: Matrix metalloproteinases (MMPs) and Tribbles 3 (Trb3) human homologue have been reported to induce atherosclerosis. We wanted to evaluate the association of circulating le... Continue reading >>

Diabetes Research And Treatment : Open Access

Diabetes Research And Treatment : Open Access

Diabetes Research and Treatment : Open Access Diabetes Research and Treatment Open Access journal aims to serve the Diabetes research community. Diabetes Research and Treatment journal focus on innovative research, preventive measures, therapeutic treatment, Diabetic education, management, and related disorders. Diabetes is rampant disease in most of the world's nations. The term diabetes describes an increase level of glucose or sugar levels in blood. Diabetes is further classified as Diabetes mellitus and Diabetes insipidus. Diabetes mellitus involves blood sugar levels and further classified as Type I diabetes IDDM (Insulin-Dependent Diabetes Mellitus) and Type II diabetes NIDDM (Non Insulin-Dependent Diabetes Mellitus). Whereas, Diabetes insipidus is the result of problems associated with Anti Diuretic Hormone (ADH) and its receptors. Both diabetes mellitus and diabetes insipidus cause polydipsia and polyuria. Polyphagia is addition to the above symptoms for diabetes mellitus. NIDDM is more common than IDDM. Type I diabetes mellitus treatment is a routine day task includes daily insulin injections and daily blood glucose testing. Exercise and strict diet regime plays a key role in controlling both Type I and II diabetes. In occasional cases, insulin injections might administer for type II diabetes mellitus. Diabetes Research and Treatment journal focused on innovative research, preventive measures, pharmacological treatment, Diabetic education, management, and disorders associated to it. This Journal covers wide range of topics such as Gestational Diabetes, Vascular diseases, Nephropathy, Hypertension, Metabolic Syndrome, Endocrinology, Diabetes Therapy, Diabetic Drugs, etc. Aperito promises efficient Editorial board with quality peer reviews for submitted original Continue reading >>

Diabetes Journals | Diabetes Management

Diabetes Journals | Diabetes Management

h5-index citation: 9 h5-median citation: 18 Diabetes Management Journal intends to publish peer-reviewed, original articles that address the global health concerns related to diabetes. It provides clinicians with the latest findings and opinions on the optimum therapies to check the ever expanding diabetes. It is an open access, online, international journal with a primary objective to reach the readers and researchers globally. Diabetes Management presents findings, analysis and commentary on the battle with Type I and Type II diabetes. Articles published in Diabetes Management address improvements in current therapeutics and patient compliance together with perspectives on future prospects. Coverage focuses on the key objective of stabilizing blood glucose levels in individuals with either form of the disease, and the associated issues of patient co operation and education. The journal also reflects the frontiers of current research, such as attempts to recreate pancreatic cells through stem cell technology or islet cell transplantation, the development of a vaccine for Type 1 disease and the potential for biomarkers to be used for the detection. The increasing understanding of the molecular basis of the disease and associated genetics will play an important part in future diabetes management. The journal encourages broader research perspectives including Clinical Care, Education and Nutrition to fight diabetes. The journal also focuses on aspects involving Psychosocial Research, Epidemiology, Health Services Research on Emerging Treatments and Technologies to deal with Pathophysiology, Complications, Cardiovascular and Metabolic Risk. INDEXING: EMBASE, Excerpta Medica, CAS (Chemical Abstracts Service), EMCare, CNKI (China National Knowledge Infrastructure) Submit yo Continue reading >>

Journal Of Diabetes Research And Clinical Metabolism Subject Areas

Journal Of Diabetes Research And Clinical Metabolism Subject Areas

completed his Ph.D. at University College London. He held postdoctoral fellowships at National Institute for medical Research, University of Oxford and University of Illinois. Grants totaling over 18 million from MRC, BHF, Welcome Trust, NHMRC, NHF and the Drug Industry to support his work over the years. Dr. Geoffrey's major research interest has been autonomic neurotransmission and he is best known for his seminal discovery and definition of P2 purinergic receptors, their signaling pathways and functional relevance. The University of Rochester, USA. He has experience in teaching over 35 years. He has been a clinical investigator for about 500 publications. Dr. Gerich has also served as Program Director of the NIH funded Clinical Research Center (CRC). His research examines hormone-substrate control of glucose homeostasis and of hypoglycemia counter regulation by evaluating the role of the kidney. presently working as Professor of Medicine and in charge of the Medical Curriculum in Internal Medicine, Medical University Graz, Austria. Dr. Hermann has played a vital role in the organisation of several national and European congresses. His research is focused on Nutritional Therapy and Dietetics. acts as professor of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus, Denmark. His extensive experience is with animal (in vivo and in vitro) and human intervention studies in relation to carbohydrate-and lipid metabolism, cardiovascular risk factors, prevention of metabolic syndrome and diabetes, molecular biology. Professor of Nutritional Sciences, The University of Alabama, USA. Her major research is focused on Mechanisms associated with body tissue partitioning during childhood, with the central focus of reciprocal interplay between bone and adipose Continue reading >>

Diabetes Research And Clinical Practice

Diabetes Research And Clinical Practice

A Thimmappaiah Jagadeesh et al. Diabetes Res Clin Pract 134, 1-7. J Weiss et al. Diabetes Res Clin Pract 134, 29-37. KK Dhatariya. Diabetes Res Clin Pract 135, 227-228. L Blonde et al. Diabetes Res Clin Pract 133, 150-158. L Blonde et al. Diabetes Res Clin Pract 133, 150-158. L Blonde et al. Diabetes Res Clin Pract 133, 150-158. Y Yue et al. Diabetes Res Clin Pract 133, 124-130. PY Ko et al. Diabetes Res Clin Pract 133, 115-123. JV Sagen et al. Diabetes Res Clin Pract 133, 142-149. D Almahfoodh et al. Diabetes Res Clin Pract 133, 104-108. P Corsenac et al. Diabetes Res Clin Pract 133, 193-203. D Benaiges et al. Diabetes Res Clin Pract 133, 85-91. M Rodacki et al. Diabetes Res Clin Pract 133, 92-103. M Luo et al. Diabetes Res Clin Pract 133, 69-77. R Garg et al. Diabetes Res Clin Pract 133, 78-84. KK Dhatariya. Diabetes Res Clin Pract 135, 227-228. K Jacques Rose et al. Diabetes Res Clin Pract. Over the last decade, advances in technology and connectivity have led to the boom of Internet-based and mobile applications (Apps) which have rendered access to information easier and faster and have changed our daily lives. With 60 million people living with diabetes (PWD) in Europe and 32 million ... J Weiss et al. Diabetes Res Clin Pract 134, 29-37. Diabetic ketoacidosis has been described in the literature as a rare possible initial presentation of acromegaly before a diagnosis of acromegaly is eventually made. Indeed, diabetic ketoacidosis is a recognised complication of acromegaly. There are a number of factors that can predispose patients w ... P Corsenac et al. Diabetes Res Clin Pract 133, 193-203. Findings contribute to obesity comparisons with other Pacific Islands, and they establish trends in New Caledonia for targeting policies and strategies of prevention. Diabetes Continue reading >>

Diabetes Therapy

Diabetes Therapy

Research, treatment and education of diabetes and related disorders Diabetes Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 34 weeks from acceptance). The journal is dedicated to the publication of high quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of diabetes therapies. Studies relating to diagnosis, devices and diabetes technology, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world. Articles published inDiabetes Therapymay be accompanied by lay-level summaries, to assist patients (and caregivers) in understanding important medical advances. Moving forward from traditional publishing, Diabetes Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself. Diabetes Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes Continue reading >>

Diabetes Journal | Integrative Obesity & Diabetes | Diabetes Research Journal - Oatext

Diabetes Journal | Integrative Obesity & Diabetes | Diabetes Research Journal - Oatext

Tohoku University Graduate School of Biomedical Engineering Integrative Obesity and Diabetes is a peer-reviewed, online open access journal dedicated to publish articles in all areas of endocrinology, obesity and diabetes. The journal prioritises to publish high quality papers focused on cutting edge research in the prevention, pharmacological treatment, management, and education in any aspect of endocrionolgy, obesity, diabetes and related disorders. Integrative Obesity and Diabetes is publishing the articles concerned with all aspects of metabolic regulation related to type 1 and type 2 diabetes, gestational diabetes,recent advances dealing with etiology and treatment of metabolic disturbances associated with obesity and diabetes, involving endocrinology, molecular/genetic, biochemical, neuroanatomical, systems biology, dietary, metabolic and integrative physiological approaches, peripheral and central regulatory pathways of carbohydrate, lipid and energy homeostasis in humans and animals. Interventions could include diet, exercise, lifestyle, surgery, and/or pharmacotherapies. Integrative Obesity and Diabetes (IOD) accepts original research articles, review articles, editorial, case reports and short communications on all the aspects (genetic, molecular, biochemical and physiological) of endocrinology, obesity and diabetes for review and possible publication. The journal invites review articles that are balanced, comprehensive and provide new and/or critical analysis of any aspect of drug therapy (or non-pharmacological intervention) relevant to patients with diabetes, obesity or related disorders. The journal will also consider publication of letters to the editor commenting on research already published in the journal, as well as manuscripts describing new hypothe Continue reading >>

Journal Of Diabetes & Metabolism

Journal Of Diabetes & Metabolism

The Journal of Diabetes & Metabolism is an open access publication that features scientific works of considerable significance and impact in all fields of Diabetes research such as: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Monogenic Diabetes, and cystic fibrosis-related diabetes, Latent autoimmune diabetes of adults (LADA), Diabetic Neuropathy, Diabetic Retinopathy, Diabetic Nephropathy, Diabetic hypoglycemia, and Obesity. The scope of the journal is not just restricted to Diabetes alone; works related to endocrinology, genetics, physiology, or cardio-vascular diseases which are loosely associated with Diabetes are equally welcome. It is a boon for researchers and students who wish to be kept abreast of the latest advancements in the field of Diabetes, it would help them build on the current know-how. Business people, policy makers, journalists, and practitioners can also benefit from the works published in the journal. The journal is helmed by a highly accomplished editorial board which comprises of acclaimed scientists from all over the world. Each individual article is peer reviewed and approved for publication by eminent scientists in the field of Diabetology. The journal maintains the highest standards in terms of quality of content published. In addition to Research Articles, the Journal also publishes high quality Commentaries, Reviews, Perspectives, and Case Reports. The Journal of Diabetes & Metabolism aims to provide all the authors with an efficient, constructive, and courteous editorial process. The journal believes in expediting the publishing process; towards this end, the journal also provides advance posting of the accepted articles. This journal ensures the barrier-free distribution of its content on online and thus, helps in improving th Continue reading >>

More in diabetes